AI assistant
Sending…
METLIFE INC — Director's Dealing 2022
Aug 23, 2022
29995_dirs_2022-08-23_9bc7b46e-f130-49a7-a5f9-fb3a4046a0d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2022-08-19
Reporting Person: DEBEL MARLENE (EVP & Chief Risk Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-19 | Common Stock | M | 5513 | $31.15 | Acquired | 59359 | Direct |
| 2022-08-19 | Common Stock | S | 4060 | $67.60 | Disposed | 55299 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-19 | Employee Stock Options (right to buy) | $31.15 | M | 5513 | Disposed | 2023-02-25 | Common Stock (5513.0) | Direct |
Footnotes
F1: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 19, 2022 and related tax obligations and fees.
F2: The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.
More from METLIFE INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 19